Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
Li H, Peng Z, Zhu J, Zhao W, Huang Y, An R, Zheng H, Qu P, Wang L, Zhou Q, Wang D, Lou G, Wang J, Wang K, Kong B, Xie X, Yin R, Low J, Rozita AM, Sen LC, Meng YC, Kiong KS, Liu J, Liang Z, Lv W, Zhu Y, Hu W, Sun W, Su J, Wang Q, Zang R, Ma D, Gao Q.
Li H, et al. Among authors: wang l, wang k, wang j, wang d, wang q.
BMC Med. 2024 May 16;22(1):199. doi: 10.1186/s12916-024-03409-9.
BMC Med. 2024.
PMID: 38755585
Free PMC article.
Clinical Trial.